Evidence
What the research shows
Oral combination targets BPC-157's GI healing + TB-500's systemic actin-binding effects.
Loading catalog
Pulling latest protocols
Encyclopedia / Recovery
Oral BPC-157 + TB-500 blend for non-injectable recovery.
Evidence
Oral combination targets BPC-157's GI healing + TB-500's systemic actin-binding effects.
Protocol
8-12 weeks; one capsule per day.
Safety
Avoid in pregnancy / active malignancy.
Best for
Users avoiding injections who want both healing mechanisms.
Not for
Acute injuries needing local subcutaneous BPC-157.
Build your stack
Pepzilla matches it with the right companions, dosing, and lifestyle rails for your goals — calibrated in 60 seconds.